0.776 0.008 (1.04%) | 11-28 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 0.98 | 1-year : | 1.1 |
Resists | First : | 0.84 | Second : | 0.94 |
Pivot price | 0.78 ![]() |
|||
Supports | First : | 0.67 | Second : | 0.55 |
MAs | MA(5) : | 0.73 ![]() |
MA(20) : | 0.78 ![]() |
MA(100) : | 1.03 ![]() |
MA(250) : | 1.56 ![]() |
|
MACD | MACD : | -0.1 ![]() |
Signal : | -0.1 ![]() |
%K %D | K(14,3) : | 41.9 ![]() |
D(3) : | 32.8 ![]() |
RSI | RSI(14): 49 ![]() |
|||
52-week | High : | 2.74 | Low : | 0.57 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ VNRX ] has closed above bottom band by 47.4%. Bollinger Bands are 27% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 0.82 - 0.82 | 0.82 - 0.83 |
Low: | 0.74 - 0.75 | 0.75 - 0.75 |
Close: | 0.77 - 0.78 | 0.78 - 0.78 |
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
Mon, 27 Nov 2023
IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying By ... - Investing.com UK
Fri, 17 Nov 2023
Volition Presents at the 5th Annual Congress of the International ... - InvestorsObserver
Tue, 14 Nov 2023
VolitionRx Limited Announces Third Quarter 2023 Financial Results ... - PR Newswire
Wed, 08 Nov 2023
VolitionRx Limited Schedules Third Quarter 2023 Earnings ... - Valdosta Daily Times
Mon, 06 Nov 2023
Ailing Pope Francis meets with European rabbis and condemns ... - Oil City Derrick
Mon, 06 Nov 2023
Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland - BioSpace
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
AMEX
|
|
Sector:
Healthcare
|
|
Industry:
Diagnostics & Research
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |